156 related articles for article (PubMed ID: 37733356)
1. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
[TBL] [Abstract][Full Text] [Related]
4. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013876. PubMed ID: 34291813
[TBL] [Abstract][Full Text] [Related]
9. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM
Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989
[TBL] [Abstract][Full Text] [Related]
10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
11. Effect of Perioperative Gabapentin Use on Postsurgical Pain in Patients Undergoing Head and Neck Mucosal Surgery: A Randomized Clinical Trial.
Townsend M; Liou T; Kallogjeri D; Schoer M; Scott-Wittenborn N; Lindburg M; Bottros M; Jackson RS; Nussenbaum B; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):959-966. PubMed ID: 29710075
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
[TBL] [Abstract][Full Text] [Related]
13. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
[TBL] [Abstract][Full Text] [Related]
14. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
[TBL] [Abstract][Full Text] [Related]
17. Natural trajectory of recovery of COVID-19 associated olfactory loss.
Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
[TBL] [Abstract][Full Text] [Related]
18. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
Hah J; Mackey SC; Schmidt P; McCue R; Humphreys K; Trafton J; Efron B; Clay D; Sharifzadeh Y; Ruchelli G; Goodman S; Huddleston J; Maloney WJ; Dirbas FM; Shrager J; Costouros JG; Curtin C; Carroll I
JAMA Surg; 2018 Apr; 153(4):303-311. PubMed ID: 29238824
[TBL] [Abstract][Full Text] [Related]
19. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
[TBL] [Abstract][Full Text] [Related]
20. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial.
Horne AW; Vincent K; Hewitt CA; Middleton LJ; Koscielniak M; Szubert W; Doust AM; Daniels JP;
Lancet; 2020 Sep; 396(10255):909-917. PubMed ID: 32979978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
